Tsamouri Maria Malvina, Steele Thomas M, Mudryj Maria, Kent Michael S, Ghosh Paramita M
Veterans Affairs-Northern California Health System, Mather, CA 95655, USA.
Department of Urologic Surgery, School of Medicine, University of California Davis, Sacramento, CA 95718, USA.
Biomedicines. 2021 Oct 14;9(10):1472. doi: 10.3390/biomedicines9101472.
Muscle-invasive urothelial carcinoma (MIUC) is the most common type of bladder malignancy in humans, but also in dogs that represent a naturally occurring model for this disease. Dogs are immunocompetent animals that share risk factors, pathophysiological features, clinical signs and response to chemotherapeutics with human cancer patients. This review summarizes the fundamental pathways for canine MIUC initiation, progression, and metastasis, emerging therapeutic targets and mechanisms of drug resistance, and proposes new opportunities for potential prognostic and diagnostic biomarkers and therapeutics. Identifying similarities and differences between cancer signaling in dogs and humans is of utmost importance for the efficient translation of in vitro research to successful clinical trials for both species.
肌层浸润性尿路上皮癌(MIUC)是人类最常见的膀胱恶性肿瘤类型,在犬类中也是如此,犬类是这种疾病的天然发病模型。犬类是具有免疫能力的动物,它们与人类癌症患者共享风险因素、病理生理特征、临床症状以及对化疗药物的反应。本综述总结了犬类MIUC发生、发展和转移的基本途径、新出现的治疗靶点和耐药机制,并提出了潜在的预后和诊断生物标志物及治疗方法的新机遇。识别犬类和人类癌症信号传导之间的异同对于将体外研究有效转化为针对这两个物种的成功临床试验至关重要。